Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FLVTW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,552
Award facts
- Contract value 100% obligated
- $19,552.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,552.30 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen injections in 2 ml formulations on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, reflecting the Defense Health Agency's ongoing pharmaceutical supply needs for military beneficiaries and personnel.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's substantial federal contracting portfolio and demonstrated capability to deliver specialized pharmaceutical products through competitive procurement make it a critical vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FLVTW?
SPE2DB25FLVTW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FLVTW worth?
The government has obligated $19,552 on SPE2DB25FLVTW.
Is contract SPE2DB25FLVTW an order under another contract?
Yes. SPE2DB25FLVTW is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB25FLVTW competed?
The extent of competition for SPE2DB25FLVTW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award